Corvus Pharmaceuticals, Inc.

Q4 2020 13F Holders

Symbol
CRVS
CUSIP
221015100
Type
Equity
Class
COM
Num filers
40
Total reported value, excl. options
$58.1M
Manager Report Date Value ($000) Shares